News FDA approval for 23andMe's direct-to-consumer genetics test Service can now be marketed as test for Alheimer's and Parkinson's, among others.
News Better slashes staff in another digital health retreat Company will cut its headcount by 35%, as it waits for an FDA decision on its diabetes DTx.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
